List view / Grid view
3 June 2015 | By Victoria White
Janssen Research & Development has announced data from a Phase 3 study of trabectedin (YONDELIS) in patients with two common types of soft tissue sarcoma...
3 June 2015 | By Victoria White
AbbVie has announced findings from a Phase 2 study of a veliparib regimen in patients with non-small cell lung cancer (NSCLC) who are current smokers...
1 June 2015 | By Victoria White
A new study compared the effectiveness of cabazitaxel alone versus cabazitaxel combined with carboplatin in patients with mCRPC...
11 May 2015 | By Victoria White
Roche has announced that data from 10 of its approved cancer medicines and 10 of its investigational medicines will be presented at this year’s American Society of Clinical Oncology Annual Meeting (ASCO 2015).
3 June 2014 | By Amgen
Amgen announced new data from two key clinical trials that support the potential of talimogene laherparepvec, a novel, investigational oncolytic immunotherapy, as both a single agent and as part of a combination regimen in patients with metastatic melanoma...
22 May 2014 | By Novartis
Novartis will showcase the results of research efforts to target disease pathways with more than 150 abstracts at two upcoming cancer-focused meetings...
15 May 2014 | By AstraZeneca
New data from AstraZeneca’s investigational cancer medicines demonstrate the rapid progression of its oncology pipeline...
14 May 2014 | By Roche
Roche announced that new data on nine approved and 18 investigational medicines will be presented during the 50th American Society of Clinical Oncology Annual Meeting...
15 May 2013 | By Roche
Early stage data on investigational anti-PDL1 immunotherapy...
